Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

A woman's rare ovarian tumor was treated with surgery, which stopped her symptoms and normalized her hormone levels.

Finasteride 1mg helps reverse hair miniaturization in men and postmenopausal women.

Topical finasteride works faster and better than 17α-estradiol for postmenopausal hair loss.

High-dose finasteride effectively treats hair loss in postmenopausal women.

Oophorectomy lowers testosterone and estrogen levels in both premenopausal and postmenopausal women, with postmenopausal women still producing significant testosterone.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

A woman's excessive hair growth and high testosterone were caused by a rare ovarian tumor, which was successfully treated with surgery.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Fulvestrant solution doesn't help hair loss in men and postmenopausal women.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

An 80-year-old woman's severe hair loss was caused by a hormone-secreting ovarian tumor.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

A 46-year-old man showed symptoms of a rare condition usually seen in postmenopausal women, highlighting the need for dentist-dermatologist collaboration.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

Dutasteride is more effective for male pattern baldness than finasteride, and black cohosh extract BNO 1055 is as effective as conjugated estrogens in treating postmenopausal symptoms, with added benefits in reducing sweating and mental symptoms.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

The cause of Frontal fibrosing alopecia, a type of hair loss, is complex, likely involving immune responses and genetics, but is not fully understood.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.